A comprehensive understanding of up-regulated PD-L1 expression by IFN-γ, and its associated functions in the aggressiveness of oral cancer cells may, thus, contribute to the development of certain necessary strategies that could maximize the anticancer activities of newly identified agents. The gene discussed is IFNG; the disease is lip and oral cavity carcinoma.